HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

CARA

Cara Therapeutics Inc

Last Close
Oct 10 • 04:00PM ET
0.2537
Dollar change
-0.0060
Percentage change
-2.31 		%
Peers: AMRN ARWR AVXL BPMC GILD LGND NKTR OPK SRPT VRTX
 | Held by: VTI VXF VHT FESM CNBS
Scroll to Statements
Index- P/E- EPS (ttm)-2.04 Insider Own16.57% Shs Outstand54.48M Perf Week-8.08%
Market Cap13.92M Forward P/E- EPS next Y- Insider Trans-0.09% Shs Float45.76M Perf Month-13.56%
Income-111.08M PEG- EPS next Q-0.38 Inst Own32.32% Short Float1.82% Perf Quarter-28.09%
Sales11.00M P/S1.27 EPS this Y- Inst Trans-23.45% Short Ratio1.60 Perf Half Y-68.70%
Book/sh0.21 P/B1.20 EPS next Y- ROA-107.38% Short Interest0.83M Perf Year-84.62%
Cash/sh1.03 P/C0.25 EPS next 5Y- ROE-184.32% 52W Range0.24 - 1.68 Perf YTD-65.85%
Dividend Est.- P/FCF- EPS past 5Y-1.20% ROI-189.58% 52W High-84.90% Beta0.69
Dividend TTM- Quick Ratio4.48 Sales past 5Y115.17% Gross Margin72.30% 52W Low5.71% ATR (14)0.02
Dividend Ex-Date- Current Ratio4.59 EPS Y/Y TTM1.69% Oper. Margin-954.75% RSI (14)35.54 Volatility6.87% 8.83%
Employees55 Debt/Eq4.07 Sales Y/Y TTM-59.53% Profit Margin-1010.19% Recom2.60 Target Price1.00
Option/ShortYes / Yes LT Debt/Eq4.05 EPS Q/Q37.24% Payout- Rel Volume0.40 Prev Close0.26
Sales Surprise26.80% EPS Surprise-40.70% Sales Q/Q-85.71% EarningsAug 05 Avg Volume521.47K Price0.25
SMA20-9.68% SMA50-19.07% SMA200-54.51% Trades Volume207,735 Change-2.31%
Date Action Analyst Rating Change Price Target Change
Jun-13-24Downgrade Stifel Buy → Hold $6 → $1
Jun-13-24Downgrade Needham Buy → Hold
Jun-13-24Downgrade H.C. Wainwright Buy → Neutral
Jun-13-24Downgrade Canaccord Genuity Buy → Hold $10 → $1
Mar-08-23Downgrade BofA Securities Neutral → Underperform $13 → $6
Mar-08-22Upgrade JP Morgan Neutral → Overweight $17 → $20
Nov-01-21Resumed Canaccord Genuity Buy $33
Aug-03-21Initiated JP Morgan Neutral $16
Apr-21-20Reiterated H.C. Wainwright Buy $30 → $33
Aug-12-19Reiterated H.C. Wainwright Buy $31 → $30
Show Previous Ratings
Aug-15-24 01:55PM
Cara: Q2 Earnings Snapshot
(Associated Press Finance)
Jul-11-24 07:00AM
Cara Therapeutics Announces Exploration of Strategic Alternatives
(GlobeNewswire) +27.97%
Jun-13-24 09:51AM
Chipotle, McDonald's initiated: Wall Street's top analyst calls
(The Fly) -34.72%
Jun-12-24 04:01PM
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
(GlobeNewswire)
May-13-24 08:55PM
CARA Stock Earnings: Cara Therapeutics Misses EPS, Beats Revenue for Q1 2024
(InvestorPlace)
05:10PM Loading…
05:10PM
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
(Zacks)
04:07PM
Cara: Q1 Earnings Snapshot
(Associated Press Finance)
04:01PM
Cara Therapeutics Reports First Quarter 2024 Financial Results
(GlobeNewswire)
May-06-24 07:00AM
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
(GlobeNewswire)
Apr-02-24 07:00AM
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
(GlobeNewswire)
Mar-07-24 07:00AM
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
(GlobeNewswire) +6.05%
06:40AM
7 F-Rated Stocks to Sell in March 2024
(InvestorPlace)
Mar-05-24 09:07AM
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript
(Insider Monkey) -8.98%
07:51AM
Q4 2023 Cara Therapeutics Inc Earnings Call
(Thomson Reuters StreetEvents)
Mar-04-24 08:51PM
CARA Stock Earnings: Cara Therapeutics Misses EPS, Misses Revenue for Q4 2023
(InvestorPlace) +5.24%
05:10PM Loading…
05:10PM
Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
(Zacks)
04:21PM
Cara: Q4 Earnings Snapshot
(Associated Press Finance)
04:01PM
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
(GlobeNewswire)
Feb-12-24 04:01PM
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
(GlobeNewswire) -8.54%
Jan-22-24 10:19AM
Cara Layoffs 2024: What to Know About the Latest CARA Job Cuts
(InvestorPlace)
07:00AM
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
(GlobeNewswire)
Dec-18-23 07:00AM
Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis
(GlobeNewswire) -48.85%
Nov-14-23 11:04AM
Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2023 Earnings Call Transcript
(Insider Monkey) -7.20%
08:48AM
Q3 2023 Cara Therapeutics Inc Earnings Call
(Thomson Reuters StreetEvents)
Nov-13-23 06:00PM
Cara (CARA) Reports Q3 Earnings: What Key Metrics Have to Say
(Zacks) +12.38%
04:15PM
Cara: Q3 Earnings Snapshot
(Associated Press Finance)
04:01PM
Cara Therapeutics Reports Third Quarter 2023 Financial Results
(GlobeNewswire)
Nov-09-23 11:38AM
These Biotech Stocks Could Double Your Money, According To Analysts
(Benzinga) -6.72%
Nov-06-23 10:00AM
Earnings Preview: Cara Therapeutics (CARA) Q3 Earnings Expected to Decline
(Zacks)
Nov-02-23 07:00AM
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
(GlobeNewswire)
07:00AM Loading…
Oct-23-23 07:00AM
Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023
(GlobeNewswire)
Sep-25-23 07:00AM
Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients
(GlobeNewswire)
Sep-05-23 07:00AM
Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
(GlobeNewswire) -10.00%
Aug-10-23 02:53AM
Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript
(Insider Monkey)
Aug-08-23 05:54AM
Q2 2023 Cara Therapeutics Inc Earnings Call
(Thomson Reuters StreetEvents)
Aug-07-23 05:15PM
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
(Zacks) -5.75%
04:09PM
Cara: Q2 Earnings Snapshot
(Associated Press Finance)
04:01PM
Cara Therapeutics Reports Second Quarter 2023 Financial Results
(GlobeNewswire)
Aug-03-23 07:00AM
Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors
(GlobeNewswire)
Aug-02-23 07:00AM
Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
(GlobeNewswire)
Jul-24-23 07:00AM
Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023
(GlobeNewswire)
Jun-14-23 01:37PM
The past five years for Cara Therapeutics (NASDAQ:CARA) investors has not been profitable
(Simply Wall St.)
Jun-13-23 06:30AM
3 Small-Cap Stocks to Sell in June Before They Crash and Burn
(InvestorPlace)
Jun-02-23 06:46PM
Palo Alto Networks Set to S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
(PR Newswire)
Jun-01-23 07:00AM
Cara Therapeutics to Present at the Jefferies Healthcare Conference
(GlobeNewswire)
May-30-23 06:34PM
7 Stocks With 1,000% Upside Potential
(InvestorPlace) -7.56%
May-25-23 06:40AM
Cara Therapeutics, Inc.'s (NASDAQ:CARA) P/S Is On The Mark
(Simply Wall St.) -6.55%
May-18-23 04:53PM
Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich or Broke.
(InvestorPlace) -8.22%
02:00AM
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus
(PR Newswire)
May-16-23 11:02AM
Q1 2023 Cara Therapeutics Inc Earnings Call
(Thomson Reuters StreetEvents) +7.23%
May-15-23 05:15PM
Cara Therapeutics (CARA) Reports Q1 Loss, Tops Revenue Estimates
(Zacks)
04:07PM
Cara: Q1 Earnings Snapshot
(AP Finance)
04:01PM
Cara Therapeutics Reports First Quarter 2023 Financial Results
(GlobeNewswire)
May-04-23 09:38AM
Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 65%
(Simply Wall St.)
May-01-23 07:00AM
Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023
(GlobeNewswire)
Apr-26-23 08:00PM
CARA: What does Argus have to say about CARA?
(Argus Research)
Apr-10-23 07:00AM
Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference
(GlobeNewswire)
Apr-07-23 08:41AM
We're Not Very Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Rate
(Simply Wall St.)
Mar-14-23 07:00AM
Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report
(GlobeNewswire)
Mar-11-23 07:19AM
Things Look Grim For Cara Therapeutics, Inc. (NASDAQ:CARA) After Today's Downgrade
(Simply Wall St.)
Mar-08-23 06:59AM
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2022 Earnings Call Transcript
(Insider Monkey)
Mar-07-23 10:46AM
Metas stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market
(MarketWatch) -33.23%
10:02AM
Q4 2022 Cara Therapeutics Inc Earnings Call
(Thomson Reuters StreetEvents)
09:43AM
Cara Therapeutics stock sinks on larger-than-expected Q4 earnings miss
(Yahoo Finance Video)
08:05AM
Meta shares rise after new wave of layoffs, WeightWatchers stock makes gains after results and acquisition; Grindrs stock falls after profit drop
(MarketWatch)
Mar-06-23 07:39PM
These 2 Stocks Are Plunging After Hours Monday
(Motley Fool)
05:15PM
Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates
(Zacks)
04:01PM
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
(GlobeNewswire)
Feb-27-23 10:00AM
Will Cara Therapeutics (CARA) Report Negative Earnings Next Week? What You Should Know
(Zacks)
Feb-21-23 07:00AM
Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
(GlobeNewswire)
Feb-15-23 05:11AM
Cara Therapeutics, Inc. (NASDAQ:CARA) Analysts Just Cut Their EPS Forecasts Substantially
(Simply Wall St.)
Feb-08-23 05:00PM
Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine
(GlobeNewswire)
Jan-17-23 07:00AM
Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023
(GlobeNewswire)
Jan-03-23 07:00AM
Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference
(GlobeNewswire)
Dec-29-22 05:53AM
Cara Therapeutics (NASDAQ:CARA shareholders incur further losses as stock declines 8.8% this week, taking three-year losses to 35%
(Simply Wall St.) +8.61%
Nov-29-22 07:30AM
KemPharm Announces Appointment of Christopher Posner as New Independent Director
(GlobeNewswire)
Nov-09-22 06:08AM
Cara Therapeutics Third Quarter 2022 Earnings: Beats Expectations
(Simply Wall St.)
Nov-07-22 05:35PM
Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates
(Zacks)
04:01PM
Cara Therapeutics Reports Third Quarter 2022 Financial Results
(GlobeNewswire)
Nov-04-22 08:46AM
Why Cara Therapeutics (CARA) Might Surprise This Earnings Season
(Zacks)
Nov-03-22 07:00AM
Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors
(GlobeNewswire)
Nov-02-22 10:01AM
Analysts Estimate Affimed N.V. (AFMD) to Report a Decline in Earnings: What to Look Out for
(Zacks) -5.80%
07:00AM
Cara Therapeutics to Present at Upcoming Investor Conferences
(GlobeNewswire)
Oct-31-22 10:00AM
Cara Therapeutics (CARA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
(Zacks)
Oct-30-22 08:51AM
Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 67%
(Simply Wall St.)
Oct-24-22 07:00AM
Cara Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022
(GlobeNewswire)
Oct-18-22 09:55AM
Wall Street Analysts See a 133% Upside in Cara (CARA): Can the Stock Really Move This High?
(Zacks)
Oct-10-22 04:05PM
SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics
(PR Newswire)
Sep-28-22 07:00AM
Cara Therapeutics Announces Difelikefalin (KORSUVA®) Injection New Drug Application Has Been Submitted in Japan
(GlobeNewswire)
Sep-20-22 09:47AM
Here's Why We're Not Too Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Situation
(Simply Wall St.)
Sep-12-22 07:00AM
Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
(GlobeNewswire)
Sep-08-22 02:27PM
Cara Therapeutics Presents Results of Oral Difelikefalin In Painful Itching Disorder
(Benzinga)
08:15AM
Cara Therapeutics Presents Late-Breaking Results of the KOMFORT Phase 2 Trial of Oral Difelikefalin for Pruritus in Notalgia Paresthetica at the 31st EADV Congress
(GlobeNewswire)
Sep-06-22 07:00AM
Cara Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
(GlobeNewswire)
Aug-24-22 07:00AM
Cara Therapeutics to Host Virtual Notalgia Paresthetica Event on September 20, 2022
(GlobeNewswire)
Aug-22-22 07:00AM
Cara Therapeutics Announces KOMFORT Data Accepted for Late-Breaking Presentation at the 31st EADV Congress
(GlobeNewswire)
Aug-19-22 01:00AM
Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022
(GlobeNewswire)
Aug-08-22 05:15PM
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
(Zacks)
04:01PM
Cara Therapeutics Reports Second Quarter 2022 Financial Results
(GlobeNewswire)
Aug-04-22 08:48AM
Should You Buy Cara Therapeutics (CARA) Ahead of Earnings?
(Zacks) +12.26%
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Posner ChristopherPRESIDENT AND CEOAug 01 '24Sale0.354,1491,452172,436Aug 02 04:05 PM
Posner ChristopherPRESIDENT AND CEOMay 02 '24Sale0.753,9362,952176,585May 06 04:15 PM
Goncalves JoanaCHIEF MEDICAL OFFICERApr 05 '24Sale0.832,7532,28553,365Apr 09 04:22 PM
Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.Apr 05 '24Sale0.832,7532,28588,247Apr 09 04:21 PM
Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.Feb 29 '24Sale0.893,2932,93191,000Mar 04 04:24 PM
Posner ChristopherPRESIDENT AND CEOFeb 29 '24Sale0.895,8345,192180,521Mar 04 04:19 PM
Goncalves JoanaCHIEF MEDICAL OFFICERFeb 29 '24Sale0.893,2932,93156,118Mar 04 04:13 PM
Posner ChristopherPRESIDENT AND CEOFeb 08 '24Sale0.5335,57518,855186,355Feb 12 05:10 PM
Posner ChristopherPRESIDENT AND CEOFeb 01 '24Sale0.554,9812,740221,930Feb 05 04:26 PM
Posner ChristopherPresident and CEONov 02 '23Sale1.223,7964,631164,411Nov 03 04:37 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.